Atjaunināt sīkdatņu piekrišanu

Shock, Sepsis, and Organ Failure: Scavenging of Nitric Oxide and Inhibition of its Production 1999 ed. [Hardback]

Edited by , Edited by
  • Formāts: Hardback, 293 pages, height x width: 244x170 mm, weight: 1360 g, XIV, 293 p., 1 Hardback
  • Izdošanas datums: 18-Feb-1999
  • Izdevniecība: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • ISBN-10: 3540645446
  • ISBN-13: 9783540645443
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 91,53 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Standarta cena: 107,69 €
  • Ietaupiet 15%
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 293 pages, height x width: 244x170 mm, weight: 1360 g, XIV, 293 p., 1 Hardback
  • Izdošanas datums: 18-Feb-1999
  • Izdevniecība: Springer-Verlag Berlin and Heidelberg GmbH & Co. K
  • ISBN-10: 3540645446
  • ISBN-13: 9783540645443
Citas grāmatas par šo tēmu:
At the Sixth Wiggers Bernard Conference, a group of scientists from various fields discussed new findings relating to nitric oxide synthase inhibitor in shock, sepsis, and organ failure. This meeting was dedicated to the presentation and discussion of positive and negative findings related to the use of NOS inhibitors, the issue of specific and non-specific inhibitors and the role of nitric oxide-oxygen radical interactions. Both experimental and clinical data were presented in the trauma and sepsis field. With appropriate dosing and timing the use of NOS inhibitors seems to be beneficial at least in severe sepsis situations, but some inhibitors and overdosing can be potentially dangerous.

Papildus informācija

Springer Book Archives
Inhibition of the Overproduction of Nitric Oxide in Septic Shock Using N^(G)-Methyl-L-Arginine 1(22) D. REES Successful Administration of the NO Synthase Inhibitor 546C88 as a Delayed Continous Infusion in a Baboon Model of Septic Shock 23(22) G. SCHLAG H. REDL H. GASSER Z. KHAKPOUR J. DAVIES Clinical Aspects of Nitric Oxide (NO) Blockade with Pyridoxylated-Hemoglobin Polyoxyethylene Conjugate (PHP) 45(24) R. G. KILBOURN J. DEANGELO Norepinepherine Versus L-NMMA in Hyperdynamic Septic Shock 69(24) K. TRAGER K. M. RIEGER B. SANTAK P. RADERMACHER Roles for Induced Nitric Oxide in Endotoxic and Hemorrhagic Shock 93(26) R. T. VILLAVICENCIO B. G. HARBRECHT T. R. BILLIAR Role of Nitric Oxide in the Regulation of Cardiovascular Performance: Clinical Implication for Sepsis and Congestive Heart Failure 119(26) J. M. HARE Inducible NOS and Other Novel Mediators of Inflammation in Brain Trauma 145(18) P. M. KOCHANEK E. H. SINZ R. S. B. CLARK C. E. DIXON M. J. BELL D. W. MARION Nitric Oxide and Leukocyte Adhesion: Experience with NO Inhibitors, NO Donors and iNOS-Deficient Mice 163(24) M. J. HICKEY P. KUBES Cytokine Control of Nitric Oxide Production: Therapeutic Possibilities 187(16) T. J. EVANS Peroxynitrite: the Dark Side of Nitric Oxide -- Effect of Mercaptoethylguanidine (MEG), a Combined Inhibitor of Inducible Nitric Oxide Synthase and Scavenger of Peroxynitrite in Shock, Inflammation, and Ischemia-Reperfusion Injury 203(42) C. SZABO T. CSONT A. SZABO B. ZINGARELLI S. CUZZOCREA A. L. SALZMAN G. J. SOUTHAN Actions of Selective and Non-Selective Nitric Oxide Synthase Inhibitors on Multiple-Organ Microvascular Injury Provoked by Lipopolysaccharide 245(16) B. J. R. WHITTLE F. LASZLO Inhibition of Nitric Oxide Synthases by the 4-Amino Analogue of Tetrahydrobiopterin 261(12) E. R. WERNER K. SCHMIDT G. WERNER-FELMAYER B. MAYER Effects of Nitric Oxide Inhibitors and Hemoglobin in Sepsis 273 S. R. FISCHER D. L. TRABER